NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1669745667 MD
Verify on CMS → Amara Nandikolla, MD
Hematology & Oncology Physician in Tulsa, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 279 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
97.6/100
▲ 14 pts above national avg 83.5 · Exceptional
Industry payments
$407.98
27 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Amara Nandikolla, MD reported a CMS MIPS final score of 97.6/100 - above the 83.5 national average - and filed 1,349 Medicare Part D claims in 2023.
- 97.6/100
- MIPS score · +14 vs avg
- 1K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥84th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1669745667 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1669745667
- ENUM-MID 2012
- TAX-MID 11K Hematology &
- MIPS-ELITE 97.6/100
- RX-MID 1,349
- BOOK-THIN 95 in Oklahoma
- PHOTO-FINISH Anosheh Afghahi · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Nandikolla · thi…
Nandikolla · this provider
97.6 MIPS pts
- Maria Amaya · hi…
Maria Amaya
97.6 MIPS pts
- Anosheh Afghahi …
Anosheh Afghahi
97.6 MIPS pts
- Bayan Al Share ·…
Bayan Al Share
97.6 MIPS pts
- Issam Alawin · n…
Issam Alawin
97.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Amara Nandikolla, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amara Nandikolla, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Amara Nandikolla, MD writes more Part D claims than 77% of them and scores higher on MIPS quality than 81% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Amara Nandikolla, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Amara Nandikolla, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amara Nandikolla, MD?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,349 59% vs specialty avg
MIPS final score
97.6/100 14.1 pts vs avg
Specialty distribution in Oklahoma
How Hematology & Oncology Physician compares to other specialties among Oklahoma providers
Medicare quality performance, MIPS
Amara Nandikolla, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 97.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1669745667 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 02/22/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.5814
Final Score
Measured-score avg: 83.5
86.5348
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Amara Nandikolla, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
OU Health Partners Inc
Tulsa, OK
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amara Nandikolla, MD. Source: openpaymentsdata.cms.gov.
Total received
$408
Largest payer
PFIZER INC.
Most common payment type
Education
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,349
Total Claims
$1.9M
Total Drug Cost
279
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,252
- Total Day Supply
- 60,594
- Generic Drug Cost
- $302K
- Opioid Claims
- 97 (7.2% rate)
- Antibiotic Claims
- 55
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 2.34
- Gender Split
- 72% female / 28% male
- Age Distribution
- <65: 24, 65-74: 136, 75-84: 98, 85+: 21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amara Nandikolla, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
222 claims
- Prochlorperazine M…
Prochlorperazine Maleate
91 claims
- Ondansetron Odt 71
Ondansetron Odt
71 claims
- Hydrocodone-Acetam… 60
Hydrocodone-Acetaminophen
60 claims
- Imbruvica 46
Imbruvica
46 claims
- Letrozole 46
Letrozole
46 claims
- Hydroxyurea 38
Hydroxyurea
38 claims
- Eliquis 34
Eliquis
34 claims
| Drug | Claims |
|---|---|
| Anastrozole | 222 |
| Prochlorperazine Maleate | 91 |
| Ondansetron Odt Ondansetron | 71 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 60 |
| Imbruvica Ibrutinib | 46 |
| Letrozole | 46 |
| Hydroxyurea | 38 |
| Eliquis Apixaban | 34 |
| Tamoxifen Citrate | 31 |
| Potassium Chloride | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Amara Nandikolla, MD fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Amara Nandikolla, MD's 1,349 claims are above the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Nandikolla, both outside Oklahoma so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.6 here).
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Nandikolla.
One of 95 Hematology & Oncology Physician providers enrolled in Oklahoma, 5 are shown here.
Dr. Sakher Abdullah
MD
Oklahoma City, OK
Dr. Bilal Ahmad
M.D
Oklahoma City, OK
Dr. Bashar Alasad
M.D.
Oklahoma City, OK
Dr. Jess Armor
M.D.
Oklahoma City, OK
Dr. Adam Asch
M.D.
Oklahoma City, OK
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Amara Nandikolla, MD's specialty? ▼
Amara Nandikolla, MD specializes in Hematology & Oncology Physician and practices in Tulsa, Oklahoma. Credentials: MD.
How much does Amara Nandikolla, MD prescribe under Medicare Part D? ▼
In 2023, Amara Nandikolla, MD wrote 1,349 Medicare Part D claims totaling $1.9M in drug costs for 279 beneficiaries.
What is Amara Nandikolla, MD's Medicare quality score? ▼
Amara Nandikolla, MD has a CMS MIPS Final Score of 97.6/100 (Quality: 86.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Amara Nandikolla, MD located? ▼
Amara Nandikolla, MD is located at 1245 S UTICA AVE, Tulsa, OK, 74104. Phone: (918) 579-3850.
What is Amara Nandikolla, MD's NPI number? ▼
Amara Nandikolla, MD's National Provider Identifier (NPI) is 1669745667, issued on 02/22/2012.
Does Amara Nandikolla, MD prescribe opioids? ▼
Yes, Amara Nandikolla, MD had 97 opioid claims in 2023 with an opioid prescribing rate of 7.2%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Amara Nandikolla, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Amara Nandikolla, MD's most frequently prescribed drugs include Anastrozole, Prochlorperazine Maleate, Ondansetron Odt. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amara Nandikolla, MD accept Medicare? ▼
Amara Nandikolla, MD appears in CMS Medicare data with 1,349 Part D claims and 279 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amara Nandikolla, MD's credentials? ▼
Amara Nandikolla, MD's NPI is 1669745667 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.